MedTrace Logo

Electrical Acupoint Stimulation for Postoperative Recovery

NCT03249701 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2018-04-02

No results posted yet for this study

Summary

This study investigates electrical acupoint stimulation (EAS) administered in peri-operation for improving postoperative recovery in elder patients, who accept knee arthroplasty. the surgery cause to change of stress response, which might be associated with postoperative recovery of patient Totally, three groups are created, 1/3 participants receive transcutaneous electrical acupoint stimulation, 1/3 participants receive electroacupuncture, the rest 1/3 will use sham transcutaneous electrical acupoint stimulation.

Conditions

  • Postoperative Complications
  • Postoperative Nausea and Vomiting
  • Postoperative Infection
  • Postoperative Delirium
  • Postoperative Pneumonia
  • Deep Vein Thrombosis
  • Postoperative Retention of Urine
  • Postoperative Recovery

Interventions

DEVICE

Transcutaneous Electrical Acupoint Stimulation

The intervention will be administered by electrical acupoint machine, the brand is Great Wall.

DEVICE

Electroacupuncture

The intervention will be administered by electrical acupoint machine, the brand is Great Wall.

DEVICE

sham Transcutaneous Electrical Acupoint Stimulation

The intervention will be administered by transcutaneous electrical acupoint machine, even no truly actualized.

Sponsors & Collaborators

  • Shandong University of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

  • Su Fan, MD · Affiliated Hospital of Shandong University of Traditional Chinese Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-01
Primary Completion
2019-05-01
Completion
2019-10-30

Countries

  • China

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03249701 on ClinicalTrials.gov